Now showing items 1-2 of 2

    • Determining the repertoire of IGH gene rearrangements in order to develop molecular markers for minimal residual disease in acute lymphoblastic leukemia 

      Brisco, Michael; Latham, Susan Elizabeth; Sutton, Rosemary; Hughes, Elizabeth; Wilczek, Vicki Jane; van Zanten, Katrina; Budgen, Bradley John; Bahar, Anita Y; Malec, Maria; Kuss, Bryone Jean; Waters, Keith; Venn, Nicola C; Giles, Jodie E; Haber, Michelle; Norris, Murray D; Marshall, Glenn M; Morley, Alexander Alan; Sykes, Pamela Joy (Elsevier, 2009)
      Molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemia were identified by determining, at the time of diagnosis, the repertoire of rearrangements of the immunoglobulin heavy chain (IGH) ...
    • Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukaemia 

      Morley, Alexander Alan; Latham, Susan Elizabeth; Brisco, Michael; Sykes, Pamela J; Sutton, Rosemary; Hughes, Elizabeth; Wilczek, Vicki Jane; Budgen, Bradley John; van Zanten, Katrina; Kuss, Bryone Jean; Venn, Nicola C; Norris, Murray D; Crock, Catherine; Storey, Colin; Waters, Keith; Revesz, Tamas (Elsevier, 2009-05)
      A sensitive and specific quantitative real-time polymerase chain reaction method, involving three rounds of amplification with two allele-specific oligonucleotide primers directed against an rearrangement, was developed ...